Xian International Medical Stock EBITDA
| 000516 Stock | 6.13 0.10 1.66% |
Xian International Medical fundamentals help investors to digest information that contributes to Xian International's financial success or failures. It also enables traders to predict the movement of Xian Stock. The fundamental analysis module provides a way to measure Xian International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xian International stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -296.5 M | -281.7 M |
Xian | EBITDA |
Xian International Medical Company EBITDA Analysis
Xian International's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Xian International EBITDA | 607 M |
Most of Xian International's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xian International Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Xian Ebitda
Ebitda |
|
According to the company disclosure, Xian International Medical reported earnings before interest,tax, depreciation and amortization of 607 M. This is much higher than that of the Broadline Retail sector and significantly higher than that of the Consumer Discretionary industry. The ebitda for all China stocks is notably lower than that of the firm.
Xian EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xian International's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xian International could also be used in its relative valuation, which is a method of valuing Xian International by comparing valuation metrics of similar companies.Xian International is currently under evaluation in ebitda category among its peers.
Xian Fundamentals
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0134 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 17.86 B | ||||
| Shares Outstanding | 2.26 B | ||||
| Shares Owned By Insiders | 34.90 % | ||||
| Shares Owned By Institutions | 3.68 % | ||||
| Price To Book | 3.79 X | ||||
| Price To Sales | 2.84 X | ||||
| Revenue | 4.62 B | ||||
| Gross Profit | (201.57 M) | ||||
| EBITDA | 607 M | ||||
| Net Income | (368.36 M) | ||||
| Total Debt | 4.68 B | ||||
| Book Value Per Share | 1.70 X | ||||
| Cash Flow From Operations | 1.09 B | ||||
| Earnings Per Share | (0.16) X | ||||
| Target Price | 7.2 | ||||
| Number Of Employees | 8.17 K | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 13.86 B | ||||
| Total Asset | 11.32 B | ||||
| Retained Earnings | 274.1 M | ||||
| Working Capital | (2.2 B) | ||||
| Net Asset | 11.32 B |
About Xian International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xian International Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xian International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xian International Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Xian Stock
Xian International financial ratios help investors to determine whether Xian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xian with respect to the benefits of owning Xian International security.